A Chinese Drugmaker Has Started Mass-Producing an Experimental Drug for COVID-19
Wang Chen, first on the right, vice president of the Chinese Academy of Engineering and president of the Chinese Academy of Medical Sciences, speaks at a conference in Wuhan, central China's Hubei Province, Feb. 5, 2020. The registration for clinical trials on the antiviral drug remdesivir has been approved, and the first batch of pneumonia patients infected by the novel coronavirus are expected to start taking the drug on Thursday, according to an official conference Wednesday.
Suzhou-based BrightGene Bio-Medical Technology said in a statement filed to the Shanghai Stock Exchange on Tuesday night that it has developed the technology to synthesize the active pharmaceutical ingredients of remdesivir, Gilead’s drug that is a leading candidate to treat the highly-infectious virus that’s killed more than 1,000 people. The drug isn’t licensed or approved anywhere in the world yet.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
The WHO Has Declared a Formal Name for the New Coronavirus Disease. Why Does the Name Matter?What’s in a Name? Why WHO’s Formal Name for the New Coronavirus Disease Matters
Baca lebih lajut »
The Coronavirus Now Has An Official NameThe World Health Organization has designated the virus "Covid-19."
Baca lebih lajut »
Trump Proposes 16% Cut To CDC As Global Number Of Coronavirus Infections And Deaths RisePresident Trump proposed a 16% cut to the CDC as the coronavirus continues to spread by lisettevoytko
Baca lebih lajut »
China launches coronavirus tracking app as death toll surpasses 1,000Dubbed the 'close contact detecter,' the smartphone app aims to let people know if they are at risk of catching the disease based on whether they have been in close proximity with someone who has it.
Baca lebih lajut »